Key facts
- CognitiveCare’s last known valuation is $8.9M (Jan 2020).
- It has raised $1.2M; the latest was Later Stage VC in Apr 2025.
- Notable investors include AWS Startups, Gates Foundation, Walsh Karra Holdings.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for CognitiveCare
- ·The full record, as it builds
Funding rounds
No funding rounds for CognitiveCare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CognitiveCare
Developer of an AI platform designed to accelerate drug discovery and development and improve health outcomes. The company offers pioneering patented technology, published research and proven performance, enabling healthcare and life sciences professionals to advance therapies and support post-market effectiveness.
- Sector
- Healthcare
- HQ
- Milpitas, CA, United States
- Founded
- 2018
- Employees
- 17
- Website
- cognitivecare.com/
- Ownership
- Privately Held (backing)
CognitiveCare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CognitiveCare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CognitiveCare in its N-PORT filings yet. We sweep new filings monthly.